Tellgen Corporation (SHE:300642)
China
· Delayed Price · Currency is CNY 17.95
+0.43 (2.45%)
Mar 10, 2026, 3:04 PM CST
Tellgen Company Description
Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally.
The company offers tumor markers; cervical cancer and HPV testing kits; Y chromosome microdeletions test kits; autoimmune; tumor methylation; cardiovascular, eugenics, and inflammation.
It also provides diagnostic reagents/testing instruments and assembly lines. The company was founded in 2003 and is based in Shanghai, China.
Tellgen Corporation
| Country | China |
| Founded | 2003 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 522 |
| CEO | Jian Er Yao |
Contact Details
Address: No. 412 Huiqing Road Shanghai, 201203 China | |
| Phone | 86 21 5086 2711 |
| Website | tellgen.com |
Stock Details
| Ticker Symbol | 300642 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002P42 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Jian Er Yao | Non-Independent Chairman of Board and GM |
| Songtao Li | Financial Manager and Accounting Supervisor |
| En Huan Yang | Deputy GM and Non-Independent Director |
| Xiaoqing Wang | Deputy GM, Secretary of Board of Directors, Director of GM's Office and Non-Independent Director |
| Ye Sheng | Director of Research & Development and Deputy GM |